Optimal Scan Time of 18F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer. Issue 24 (June 2015)

• Record Type: Journal Article
• Authors: Zhang, Wen-Qian; Fu, Yi-Li; Hu, Bin; Chen, Shuo; Yang, Min-Fu; Li, Hui; Lawen., Alfons
• Is Part Of: Medicine. Volume 94:Issue 24(2015)
• Publication Date: 2015-06
• Subjects: Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000000884
• Languages: English
• ISSNs: 0025-7974

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>Positron emission tomography (PET)/computed tomography (CT)–guided radiofrequency ablation (RFA) has become a major treatment approach for small tumors. Identifying this quantitative dynamic ¹⁸F-2-fluoro-2-deoxy-d-glucose (¹⁸F-FDG) activity at the primary lesion can minimize misdiagnosis and allow an opportunity to reintervene.</p> <p>Here, we report 3 patients with nonsmall cell lung cancer (NSCLC) who underwent the ablative therapy with split-dose ¹⁸F-FDG fused PET/CT scans for early identification of residual tumors and follow-up evaluation of treatment.</p> <p>Our results indicate that reliable post-RFA imaging follow-up is critical in fast and efficient assessment of complete tumor resection in patients experienced the ablation procedure.</p> </sec> </abstract>